Related Experiment Video
Updated: Jun 29, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Statins and stroke
A Bersano1, E Ballabio, S Lanfranconi
1IRCCS Foundation Ospedale Maggiore Policlinico Mangiagalli and Regina Elena, Via F. Sforza 35, 20122 Milan, Italy. anna.bersano@unimi.it
Insights
Statins effectively reduce stroke risk in high-risk patients and may decrease stroke recurrence. Their favorable safety profile, with rare and reversible side effects, supports their use in stroke prevention strategies.
Area of Science:
- Cardiovascular Pharmacology
- Cerebrovascular Disease Research
- Atherosclerosis and Thrombosis Studies
Background:
- Statins exhibit pleiotropic effects beyond LDL-C reduction, influencing plaque stability, endothelial function, inflammation, and thrombosis.
- While LDL-C is linked to coronary heart disease, its association with stroke incidence requires further clarification.
Purpose of the Study:
- To review current research on statins for primary and secondary stroke prevention.
- To analyze statin's chemical properties, mechanism of action, and safety, including hemorrhagic stroke risk.
Main Methods:
- Comprehensive review of research papers, meta-analyses, and randomized controlled trials.
- Analysis of pharmacological properties, adverse effects, and safety data related to statin therapy.
Main Results:
- Statins demonstrate a reduction in stroke occurrence among high-risk individuals.
- Evidence suggests statins may also decrease the likelihood of recurrent strokes.
Conclusions:
- Statins are beneficial in reducing stroke risk and recurrence in high-risk populations.
- The generally low incidence and reversible nature of statin side effects, coupled with an unclear link to hemorrhagic events, support their safe application.
Abstract:
Pharmacological studies highlighted pleiotropic effects of statins, that seem to influence atherogenesis not only by increasing atherosclerotic plaque stability but also by modulating endothelial function and inflammation and acting on platelet aggregation and thrombosis. Despite a strong association between increased levels of low-density lipoprotein cholesterol (LDL-C) and the incidence of coronary heart disease (CHD) has been well proven, it not yet established whether serum LDL-C levels are related to stroke incidence. The major aim of this paper is to perform a comprehensive up-to-date review of research papers, meta-analyses and randomized controlled clinical trials reporting the effects of statins in primary and secondary stroke prevention strategies. In addition, our work provides an overview on statin chemical structure, mechanism of action and pharmacological properties, investigating also most common adverse effects and relationship between statin therapy and haemorrhagic stroke risk, in order to assess drugs safety. Although studies are heterogeneous, our analysis shows that statins reduce the risk of stroke occurrence in high risk patients and seem also to reduce stroke recurrence. Moreover, the low incidence and reversibility of adverse effects, and the unclear association with hemorrhagic events, support the safe use of these drugs.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Ischemic Stroke l: Introduction
Stroke: Introduction and Types
Atherosclerosis IV: Nursing Management
Ischemic Stroke ll: Pathophysiology